Fig. 3From: The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysisEffects of the addition or replacement of capecitabine on subgroup analysis of disease-free survival (DFS)Back to article page